Find clinical trials for Non-Small-Cell Lung Cancer in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Warszawa, Mazowieckie, POL:
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Warsaw, Poland and 205 other locations
cemiplimab or docetaxel in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and...
Phase 1
Warsaw, Poland and 33 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Warszawa, Poland and 137 other locations
This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small...
Phase 3
Warszawa, Poland and 155 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Warszawa, Poland and 126 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Warszawa, Poland and 230 other locations
of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...
Phase 3
Warszawa, Poland and 168 other locations
to determine the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non...
Phase 1
Warszawa, Poland and 42 other locations
In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...
Phase 3
Warszawa, Poland and 17 other locations
The research study is testing the investigational drug necitumumab (IMC-11F8) in the treatment of advanced non-small cell ...
Phase 3
Otwock, Poland and 181 other locations
Clinical trials
Research sites
Resources
Legal